• Home
  • About
    • About us
    • Company
    • Our Team
  • Our Products

    hiPSC-Derived Cells

    • iPSC - Academia
    • Ventricular Cardiomyocytes
    • Atrial Cardiomyocytes
    • Fibroblasts
    • Smooth Muscle Cells
    • Macrophages
    • Endothelial Cells
    • Epithelial Cells

    Organoids

    • Ventricular Cardiac Organoid
    • Atrial Cardiac Organoid
    • Pancreatic Islet Organoid
    • Gut Organoid
    • Vascularized Ventricular Cardiac Organoid
    • Vascularized Atrial Cardiac Organoid
  • Services
    • PBMC Collection and iPSC Reprogramming
    • Custom Differentiated iPSCs
    • Genetically Engineered iPSCs
    • High-Throughput Drug Discovery
    • Cell Village
    • Clinical Trial in a Dish
    • CARTOX (hERG Toxicity Assay)
    • Hepatotoxicity Screen
    • Functional assays of gut barrier Integrity and Disease Modelling.
    • Pancreatic Islet Organoid – Glucose Sensitivity
  • Pipeline
  • AI
    • AI
    • Admet Ai
  • Resources
    • Publications
    • Media
    • News
    • Newsletter
    • LOS For Academic Researchers
  • Investors
  • Careers
  • Quote
  • Contact
Join Us
0 items $0.00
Menu
0 items $0.00

Posts by admin

HomeArticles Posted by admin
09 Jan
Blog

Greenstone Biosciences is proud to be a sponsor of the 2023 Stanford Drug Discovery Symposium

  • September 19, 2025
  • By author-avatar admin
  • 0 comments
Greenstone Biosciences is a proud sponsor of the 2023 

Continue reading

27 Sep
Blog

Greenstone Biosciences Secures $2.75M to Advance Revolutionary Cardiotoxicity Detection Technology

  • September 19, 2025
  • By author-avatar admin
  • 0 comments
Published: Sep 13, 2023 PALO ALTO, CA — September 12, 2023 — Greenstone Biosc...

Continue reading

13 Jul
Blog

Congratulation to Greenstone Biosciences co-founder for becoming the President of American Heart Association

  • September 19, 2025
  • By author-avatar admin
  • 0 comments
Greenstone Biosciences is excited to announce that our distinguished co-founder, Dr. Jo...

Continue reading

01 Feb
Blog

Greenstone Biosciences on a Quest for Duchenne Muscular Dystrophy Therapeutics with New Funding from CIRM

  • September 19, 2025
  • By author-avatar admin
  • 0 comments
Palo Alto, CA, February 1, 2023 – Recently, the California Institute of Regenerative Me...

Continue reading

12 Dec
Blog

Greenstone co-founder Joseph Wu inducted into NAI Class of 2022

  • September 19, 2025
  • By author-avatar admin
  • 0 comments
We want to congratulate our co-founder 

Continue reading

07 Dec
Blog

CIRM funds Greenstone Biosciences with $1.35M to accelerate drug discovery using patient – derived induced pluripotent stem cells

  • September 19, 2025
  • By author-avatar admin
  • 0 comments
Greenstone Biosciences, Inc., a computational biology driven drug discovery company,

Continue reading

01 Dec
Blog

Greenstone Bio adds Axel Brunger to the Scientific Advisory Board

  • September 19, 2025
  • By author-avatar admin
  • 0 comments
Greenstone Biosciences would like to welcome Axel Brunger of Stanfo...

Continue reading

13 Oct
Blog

CIRM Awards $1.3 million to Greenstone Bio for Innovative Cardiovascular Stem Cell Research

  • September 19, 2025
  • By author-avatar admin
  • 0 comments
Palo Alto, CA, October 04, 2022 – Greenstone Biosciences, Inc. (“Greenstone Bio”),...

Continue reading

23 Aug
Blog

Greenstone Biosciences, Inc. Announces Collaboration with the Maryland Stem Cell Research Fund to Provide Curated Induced Pluripotent Stem Cell Lines to Stem Cell Investigators Across the State of Maryland

  • September 19, 2025
  • By author-avatar admin
  • 0 comments
The stem cell lines provided through this collaboration empower Maryland stem cell scie...

Continue reading

19 Aug
Blog

Greenstone Biosciences makes human induced pluripotent stem cell lines available to academic institutions for free

  • September 19, 2025
  • By author-avatar admin
  • 0 comments
Greenstone Biosciences announces that it will be making available its collection of hea...

Continue reading

  • 1
  • 2

Greenstone Biosciences accelerates drug discovery through human-relevant NAMs and advanced AI technologies. By combining scientific expertise with innovative platforms, we deliver safer, more effective therapies to patients in less time.

Quick Links

  • Home
  • About Us
  • hiPSC-Derived Cells
  • Organoids
  • Services
  • Pipeline

Services

  • AI
  • Publications
  • News
  • Media
  • Corporate
  • Contact Us

Contact Us

  • (650)714-7060
  • info@greenstonebio.com
  • Stanford Research Park 3160 Porter Drive, Suite 140 Palo Alto, CA 94304
Jki-twitter-light Jki-linkedin-light

© 2025 Greenstone Biosciences, Inc. All rights reserved.

  • Home
  • About
    • About us
    • Company
    • Our Team
  • Our Products
    • hiPSC-Derived Cells
      • iPSC – Academia
      • Ventricular Cardiomyocytes
      • Atrial Cardiomyocytes
      • Fibroblasts
      • Smooth Muscle Cells
      • Macrophages
      • Endothelial Cells
    • Organoids
      • Ventricular Cardiac Organoid
      • Atrial Cardiac Organoid
      • Pancreatic Islet Organoid
      • Gut Organoid
      • Vascularized Ventricular Cardiac Organoid
      • Vascularized Atrial Cardiac Organoid
  • Services
    • PBMC Collection and iPSC Reprogramming
    • Custom Differentiated iPSCs
    • Genetically Engineered iPSCs
    • High-throughput Drug Discovery
    • Cell Village
    • Clinical Trial in a Dish
    • CARTOX (hERG Toxicity Assay)
    • Hepatotoxicity Screen
    • Gut Organoid Permeability Assay
    • Pancreatic Islet Organoid – Glucose Sensitivity
  • Pipeline
  • AI
    • AI
    • Admet Ai
  • Resources
    • Publications
    • Media
    • News
    • Newsletter
  • Investors
  • Careers
  • Contact us
  • Login / Register
Shopping cart
Close